Patent · US Active

Immunogenic composition

US9358279B2 · kind B2 · utility

5Cited by

47References

1Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Ralph Leon Biemans · Rixensart, BE
Dominique Boutriau · Rixensart, BE
Carine Capiau · Rixensart, BE
Philippe Denoel · Rixensart, BE
Pierre Duvivier · Rixensart, BE
Jan Poolman · Broek in Waterland, NL

Key dates

Filing date	Oct 28, 2014
Grant date	Jun 7, 2016
Priority date	—
Expiry date	Oct 28, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application discloses an immunogenic composition comprising a Hib saccharide conjugate, at least one additional bacterial, for example N. meningitidis, saccharide conjugate(s), and a further antigen selected from the group consisting of whole cell pertussis and hepatitis B surface antigen, wherein the saccharide dose of the Hib saccharide conjugate is less than 5 μg.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.